Back
Verrica Pharmaceuticals Stock Price Chart
Sponsored
VRCA
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
32
VRCA
Verrica Pharmaceuticals
Last Price:
$0.65
Seasonality Move:
24.89%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight selling pressure.
Verrica Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.68 | Sell |
20-day SMA: | 0.9 | Sell |
50-day SMA: | 1.07 | Sell |
200-day SMA: | 4.53 | Sell |
8-day EMA: | 0.71 | Sell |
20-day EMA: | 0.83 | Sell |
50-day EMA: | 1.18 | Sell |
200-day EMA: | 3.37 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 31.18 | Sell |
Chaikin Money Flow: | -553970 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.71 - 1.13) | Sell |
Bollinger Bands (100): | (0.63 - 2.89) | Sell |
Verrica Pharmaceuticals Technical Analysis
Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
-
Verrica Pharmaceuticals share price is 0.65 while VRCA 8-day simple moving average is 0.68, which is a Sell signal.
-
The stock price of VRCA is 0.65 while Verrica Pharmaceuticals 20-day SMA is 0.90, which makes it a Sell.
-
Verrica Pharmaceuticals 50-day simple moving average is 1.07 while VRCA share price is 0.65, making it a Sell technically.
-
VRCA stock price is 0.65 and Verrica Pharmaceuticals 200-day simple moving average is 4.53, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
32
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a SellThe current Verrica Pharmaceuticals [VRCA] share price is $0.65. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
58.7M
Price in USD:
0.65
Share Volume:
1.5M
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.61
Sell
32
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?The Verrica Pharmaceuticals stock price is 0.65 USD today.
-
Will VRCA stock go up or go down?Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Verrica Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
-
Verrica Pharmaceuticals share price is 0.65 while VRCA 8-day exponential moving average is 0.71, which is a Sell signal.
-
The stock price of VRCA is 0.65 while Verrica Pharmaceuticals 20-day EMA is 0.83, which makes it a Sell.
-
Verrica Pharmaceuticals 50-day exponential moving average is 1.18 while VRCA share price is 0.65, making it a Sell technically.
-
VRCA stock price is 0.65 and Verrica Pharmaceuticals 200-day simple moving average is 3.37, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.91 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
-
VRCA Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Verrica Pharmaceuticals is a Sell
-
Verrica Pharmaceuticals Relative Strength Index (RSI) is 31.18, which suggest Verrica Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Verrica Pharmaceuticals is (0.71 - 1.13), which suggest Verrica Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Verrica Pharmaceuticals is (0.63 - 2.89), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.